Global Mice Model Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Mice Model Technologies Market is presumed to reach the market size of nearly USD 12.52 BN by 2030 from USD 5.04 BN in 2022 with a CAGR of 10.64% under the study period 2023 - 2030.

Mice model technologies use different mice species in order to mimic characteristics of a biological process or a disease found in humans. These technologies have become popular because mice share mammalian features with humans and suffer from many similar diseases. Mice model technologies are highly beneficial for biomedical research. Genetic engineering is used to develop different types of mice models to target specific human conditions.

MARKET DYNAMICS:

The rise in the advancements in gene editing tools and physiological similarities between humans and mice are major factors augmenting the demand for mice model technologies. On the downside, strict regulations and guidelines imposed by various governments and growing opposition to mice testing by several organizations may restrict market expansion. Nonetheless, rising demand for humanized mouse models and increasing consumption of personalized medicine will likely impact the mice model technologies market positively.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mice model technologies. The growth and trends of mice model technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the mice model technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

CRISPR Knockout
CRISPR Knockin
Random Insertions
Large, Targeted Insertions
ES Cell Modification (Homologous Recombination)
Others

By End-User

Pharmaceutical Companies
Biotechnology Companies
Academic And Research Facilities
Contract Research And Manufacturing Organizations

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Mice Model Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mice model technologies market include Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Merck KGaA, Ozgene Pty Ltd., Taconic Biosciences Inc., PolyGene AG, The Jackson laboratory, Yale School of Medicine, University of North Carolina, University of Nebraska Medical Center, Monash University, UMass Chan Medical School, University of Bonn, Columbia University, The University of Arizona. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219536

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MICE MODEL TECHNOLOGIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By End-user
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 CRISPR Knockout Historic and Forecast Sales by Regions
6.5 CRISPR Knockin Historic and Forecast Sales by Regions
6.6 Random Insertions Historic and Forecast Sales by Regions
6.7 Large, Targeted Insertions Historic and Forecast Sales by Regions
6.8 ES Cell Modification (Homologous Recombination) Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
7.5 Biotechnology Companies Historic and Forecast Sales by Regions
7.6 Academic And Research Facilities Historic and Forecast Sales by Regions
7.7 Contract Research And Manufacturing Organizations Historic and Forecast Sales by Regions

8 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MICE MODEL TECHNOLOGIES COMPANIES

9.1. Mice Model Technologies Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF MICE MODEL TECHNOLOGIES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Biocytogen
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Charles River Laboratories
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Cyagen Biosciences
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Gempharmatech
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. genOway
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. ingenious targeting laboratory
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Merck KGaA
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Ozgene Pty Ltd.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Taconic Biosciences Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. PolyGene AG
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. The Jackson laboratory
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Yale School of Medicine
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. University of North Carolina
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. University of Nebraska Medical Center
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. Monash University
- 10.17.1. Company Overview
- 10.17.2. Company Revenue
- 10.17.3. Products
- 10.17.4. Recent Developments
10.18. UMass Chan Medical School
- 10.18.1. Company Overview
- 10.18.2. Company Revenue
- 10.18.3. Products
- 10.18.4. Recent Developments
10.19. University of Bonn
- 10.19.1. Company Overview
- 10.19.2. Company Revenue
- 10.19.3. Products
- 10.19.4. Recent Developments
10.20. Columbia University
- 10.20.1. Company Overview
- 10.20.2. Company Revenue
- 10.20.3. Products
- 10.20.4. Recent Developments
10.21. The University of Arizona
- 10.21.1. Company Overview
- 10.21.2. Company Revenue
- 10.21.3. Products
- 10.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies